25245-33-4Relevant articles and documents
Aryl iodides from aryllithiums using an iodolactone as an iodine electrophile
Harrowven, David C,Nunn, Michael I.T,Fenwick, David R
, p. 7501 - 7502 (2001)
The paper describes the use of iodolactone 2 as an iodine electrophile for transforming aryllithiums into aryl iodides.
BIARYL DERIVATIVE AS GPR120 AGONIST
-
Paragraph 0112; 0438, (2017/11/17)
The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.
THERAPEUTIC AGENT FOR HEPATITIS C
-
Page/Page column 24, (2013/02/27)
This invention provides a therapeutic agent for hepatitis C comprising, as an active ingredient, a compound having anti-HCV activity useful in treatment of hepatitis C. The therapeutic agent for hepatitis C comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.